RxDoctor Payments Data

Kestutis Boyev, MD

Otolaryngology · Tampa, FLNPI 1730114380

Payments from drug & device makers

$1,950in general payments, 2019–2025

Across 15 payments — averaging $130.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$717
  • Oticon Medical, LLC$649
  • Mizuho America, Inc.$238
  • Spirair, Inc.$154
  • Medtronic$103
  • KARL Storz Endoscopy-america$73
  • plus $17 from 1 others

What the payments were for

  • Food & beverage$1,950100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Johnson & Johnson5$717
Oticon Medical, LLC2$649
Mizuho America, Inc.1$238
Spirair, Inc.1$154
Medtronic3$103
KARL Storz Endoscopy-america2$73
Advanced Bionics, LLC1$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,950 in reported general payments places this provider in the 55th percentile of 586 otolaryngology providers in Florida.

See all otolaryngology providers in Florida

Medicare billing

Part B allowed, 2024
$54,950
Medicare patients
200
Services billed
398

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth21$2,125
Neomycin-Polymyxin-HydrocortNeomycin/Polymyxin B/Hydrocort11$663

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Tampa

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →